[1] HE S, LI H, CAO M, et al. Trends and risk factors of lung cancer in China[J]. Chin J Cancer Res, 2020, 32(6):683-694. [2] LI X M, LI F, LIU Z K, et al. Investigation of one-lung ventilation postoperative cognitive dysfunction and regional cerebral oxygen saturation relations[J]. J Zhejiang Univ Sci B, 2015,16(12):1042-1048. [3] 黑子清, 黄文起, 刘克玄, 等. 麻醉前应用抗胆碱能药物的广东省专家共识(2021版)[J]. 广东医学, 2021, 42(11):1290-1294. [4] KIM E J, UM M Y, KIM K O, et al. Safety and efficacy of glycopyrrolate as a premedication for endoscopic submucosal dissection: a randomized, double-blind, placebo-controlled study[J]. Endoscopy, 2017, 49(10):949-956. [5] CHO E A, HWANG S H, LEE S H, et al. Does glycopyrrolate premedication facilitate tracheal intubation with a rigid video-stylet?: a randomized controlled trial[J]. Medicine:Baltimore, 2018, 97(32):e11834. [6] CHABICOVSKY M, WINKLER S, SOEBERDT M, et al. Pharmacology, toxicology and clinical safety of glycopyrrolate[J]. Toxicol Appl Pharmacol, 2019, 370:154-169. [7] 陈涌鸣, 朱慧琛, 王祥瑞. 盐酸戊乙奎醚和阿托品对老年患者心率变异性及心率影响的比较[J]. 中华麻醉学杂志, 2005, 25(1):59-60. [8] 王志鹏, 赵国栋, 李真, 等. 盐酸戊乙奎醚术前应用对患者呼吸功能的影响[J]. 临床麻醉学杂志, 2012, 28(7):655-657. [9] 疏树华, 柴小青, 周玲, 等. 不同剂量盐酸戊乙奎醚对老年患者术后早期认知功能的影响[J]. 临床麻醉学杂志, 2013, 29(1):28-30. [10] HWANG J, MIN S, KIM C, et al. Prophylactic glycopyrrolate reduces hypotensive responses in elderly patients during spinal anesthesia: a randomized controlled trial[J]. Can J Anaesth, 2014, 61(1):32-38. [11] TASHKIN D P, GROSS N J. Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2018, 13:1873-1888. [12] THORBURN J R, JAMES M F, FELDMAN C, et al. Comparison of the effects of atropine and glycopyrrolate on pulmonary mechanics in patients undergoing fiberoptic bronchoscopy[J]. Anesth Analg, 1986, 65(12):1285-1289. [13] 刘爱杰, 袁莉, 柳国强, 等. 盐酸戊乙奎醚对脊柱后路全麻手术患者循环及肺顺应性的影响[J]. 中华临床医师杂志:电子版, 2013, 7(4):1762-1763. [14] 刘芳, 潘芳, 冯艺, 等. 盐酸戊乙奎醚对全麻患者肺胸顺应性的影响[J]. 临床麻醉学杂志, 2008, 24(10):839-842. [15] 黄悦. 肺表面活性物质及影响其合成的因素[J]. 国外医学:麻醉学与复苏分册, 2002, 23(5):308-309. [16] LAFORCE C, FELDMAN G, SPANGENTHAL S, et al. Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study[J]. Int J Chron Obstruct Pulmon Dis, 2016,11:1233-1243. [17] 邓惠民, 冯迪, 吕欣. 单肺通气期间低氧血症的发生机制及防治策略[J]. 临床麻醉学杂志, 2020, 36(12):1235-1238. |